期刊文献+

骨肉瘤组织中EphA2和CyclinD1的表达及临床意义

Expression and clinical significance of EphA2 and CyclinD1 in osteosarcoma tissue
原文传递
导出
摘要 目的探讨CyclinD1和EphA2在骨肉瘤组织中的表达和临床意义。方法应用免疫组织化学sP法分别对50例骨肉瘤组织、20例骨软骨瘤组织及20例正常骨组织中EphA2和CyclinD1蛋白的表达进行检测并对结果进行统计学分析。结果正常骨组织、骨软骨瘤组织CyclinD1和EphA2蛋白阳性表达率为0(0/20),骨肉瘤组织中CyclinD1和EphA2蛋白阳性表达率分别为70.00%(35/50)和78.00%(39/50),差异均有统计学意义(P〈0.05)。I级、Ⅱ级和Ⅲ级骨肉瘤组织中EphA2和CyclinD1蛋白阳性表达率在不同临床分期之间两两相比差异有统计学意义(P〈0.05)。伴有肺转移骨肉瘤组织中EphA2和CyclinD1蛋白阳性表达率与无肺转移骨肉瘤组织表达率相比,差异有统计学意义(P〈0.05)。EphA2和CyclinD1蛋白在骨肉瘤组织中的表达,经统计学分析,呈明显正相关(P〈0.01)。结论EphA2和CyclinD1蛋白表达与骨肉瘤的演进有关,EphA2和CyclinD1蛋白在骨肉瘤组织中的表达有相关性。同时,二者可能在骨肉瘤的发生、发展及浸润、转移过程中起协同作用。 Objective To study the expression and clinical significance of EphA2 and CyclinD1 in osteosarcoma tissue. Methods The expressions of EphA2 and CyclinD1 in 50 cases of osteosarcoma tis- sues, 20 cases of osteochondroma tissues and 20 cases of normal bone tissues were deteted by immunohisto- chemistry SP method, and the results were analyzed statistically. Results The positive expression rates of EphA2 and CyclinD1 proteins in normal bone and osteochondroma tissues were 0(0/20); The positive ex- pression rates of EphA2 and CyclinD1 proteins in osteosarcoma tissues were 78. 00% (39/50)and 70% (35/ 50), respectively. There were significant differences ( P 〈 0. 05 ). The positive expression rates of EphA2 and CyclinD1 proteins in osteosarcoma tissues with grade III were higher than those in grade Iand grade ]1. There were significant differences between different clinical stages (P 〈 0. 05 ). There were significant differences in the positive expression rates of EphA2 and CyclinD1 proteins in osteosarcoma tissues with and without metastasis (P 〈 0. 05). There was positive correlation of the EphA2 expression with CyclinD1 ex- pression in osteosarcoma tissues (P 〈 0. 01 ). Conclusions The expressions of EphA2 and CyclinD1 pro- teins are related with progression of osteosarcoma. There is positive correlation between the expressions of EphA2 and CyclinD1 proteins in osteosarcoma tissues. EphA2 and CyclinD1 protein can play synergistic effect on the process of occurrence, development and infiltration, metastasis of osteosarcoma.
出处 《中国实用医刊》 2012年第10期67-69,共3页 Chinese Journal of Practical Medicine
关键词 骨肉瘤 EPHA2 CYCLIND1 Osteosarcoma EphA2 CyclinD1
  • 相关文献

参考文献12

  • 1Straume O,Akslen LA. Importance of vascular phenotype by basic fibtoblast growth factor,and influence of the angiogenic factors basic fibroblast gwwth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression[J].American Journal of Pathology,2002,(03):1009-1019.doi:10.1016/S0002-9440(10)64922-X.
  • 2Nakamoto M,Bergemann AD. Diveme roles for the Eph family of receptor tyrosine kinase in carcinogenesis[J].Microscopy Research and Technique,2002,(01):58-67.doi:10.1002/jemt.10177.
  • 3Miyazaki T,Kato H,Fukuchi M. EphA2 overexpression correlates with poor prognosis in esophageal aquamous cell carcinoma[J].International Journal of Cancer,2003,(05):657-663.doi:10.1002/ijc.10860.
  • 4Kinch MS,Moore MB,Harpole DH. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and sruvival[J].2003,(02):613-618.
  • 5王蕾,何妍,李希芳,刘岩,时志民,刘惠民.大肠癌E2F-1、CyclinD1的表达及其意义[J].武警医学,2011,22(11):935-937. 被引量:4
  • 6Walker-Daniels J,Hess AR,Hendrix MJ. Differential regulation of EphA2 in norrnal and malignant cells[J].American Journal of Pathology,2003,(04):1037-1042.doi:10.1016/S0002-9440(10)63899-0.
  • 7范波,姚珍薇.EphA2在宫颈癌中表达的临床意义及与患者预后的关系[J].华西医学,2008,23(1):78-79. 被引量:2
  • 8Nakamura R,Kataoka H,Sato N. EphA2/EFNA1 expression in human gastric cancer[J].Cancer Science,2005,(01):423-447.
  • 9刘辉,郭建文,刘江惠,左连富.EphA2/EphrinA1在胃癌组织中的表达及与血管生成的关系[J].第三军医大学学报,2008,30(23):2183-2186. 被引量:9
  • 10Nadal A,Cardesa A. Molecular biology of laryngeal squamous cell carcinona[J].VIRCHOWS ARCHIV-AN INTERNATIONAL Journal OF PATHOLOGY,2003,(01):1-7.

二级参考文献43

  • 1任占平,郑绍光,陈尉麟.应用SP免疫组化染色法的体会[J].诊断病理学杂志,1994,1(3):176-176. 被引量:69
  • 2张真真,张声,林建银,黄培生,陈余鹏.促血管生成素及其受体的异常表达与胃癌血管生成的关系[J].中华肿瘤杂志,2006,28(4):280-284. 被引量:17
  • 3周慧聪,张艳,李继昌.胃癌组织中环氧合酶-2、血管内皮生长因子-C与微淋巴管密度检测[J].郑州大学学报(医学版),2006,41(6):1131-1133. 被引量:11
  • 4Fang W B, Brantley-Sieders D M, Parker M A, et al. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis[J]. Oncogene, 2005, 24(53): 7859-7868.
  • 5Miyazaki T, Kato H, Fukuchi M, et al. EphA2 ovcrexpression correlates with poor prognosis in esophageal squamous cell carcinoma [ J ]. Int J Cancer, 2003, 103(5) : 657 -663.
  • 6Brantley-Sieders D M, Fang W B, Hicks D J, et al. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression[ J]. FASEB J, 2005, 19(13) : 1884 - 1886.
  • 7Zeng G, Hu Z, Kinch M S, et al. High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia[ J]. Am J Pathol, 2003, 163(6): 2271 -2276.
  • 8Weidner N. Current pathologic methods of measuring intratumoral microvessel density within breast carcinoma and other solid tumors [ J]. Breast Cancer Res Treat, 1995, 36(2) : 169 -180.
  • 9Kamiyama M, Ichikawa Y, Ishikawa T, et al. VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice[ J ]. Cancer Gene Ther, 2002, 9 (2) : 197 -201.
  • 10Thaker P H, Deavers M, Celestino J, et al. EphA2 expression is associated with aggressive features in ovarian carcinoma [ J ]. Clin Cancer Res, 2004, 10(15) : 5145 -5150.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部